Gender-related disparities in non-small cell lung cancer

被引:27
作者
Paggi, Marco G. [2 ]
Vona, Rosa
Abbruzzese, Claudia [2 ]
Malorni, Walter [1 ,3 ]
机构
[1] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Sect Cell Degenerat & Gender Med, I-00161 Rome, Italy
[2] Natl Canc Inst Regina Elena, Dept Dev Therapeut Programs, I-00144 Rome, Italy
[3] Ist San Raffaele Sulmona, Sulmona, AQ, Italy
关键词
Cancer; Gender; Non-small cell lung cancer; Estrogens; Apoptosis; Autophagy; GROWTH-FACTOR RECEPTOR; PAPILLOMAVIRUS-16; E7; INTERACTS; NEVER-SMOKERS; ESTROGEN-RECEPTOR; BLADDER-CANCER; GENOMIC INSTABILITY; CIGARETTE-SMOKING; MTOR INHIBITORS; EGFR MUTATION; REDOX STATE;
D O I
10.1016/j.canlet.2010.08.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidemiological studies clearly outline some disparities in cancer onset, progression as well as prognosis and therapeutic response between sexes. In particular, in lung cancer, the leading cause of cancer death, at least in Western countries, a gender disparity appears now to emerge, especially for non-small cell lung cancer (NSCLC). Such a disparity is apparently due to a variety of mechanisms, ranging from genetic and epigenetic differences to gender-specific lifestyle as well as to behavioral causes and, clearly, to sex hormones activity. Here we briefly recapitulate gender differences in terms of risk factors, histopathological features and pathogenetic mechanisms in NSCLC, and hypothesize that a gender-oriented pharmacology could beneficially impact on innovative therapeutic strategies. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 99 条
[11]   Gender difference in DNA adduct levels among nonsmoking lung cancer patients [J].
Cheng, YW ;
Hsieh, LL ;
Lin, PP ;
Chen, CP ;
Chen, CY ;
Lin, TS ;
Su, JM ;
Lee, H .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2001, 37 (04) :304-310
[12]  
Cheng YW, 2001, CANCER RES, V61, P2799
[13]   Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial [J].
Chlebowski, Rowan T. ;
Schwartz, Ann G. ;
Wakelee, Heather ;
Anderson, Garnet L. ;
Stefanick, Marcia L. ;
Manson, JoAnn E. ;
Rodabough, Rebecca J. ;
Chien, Jason W. ;
Wactawski-Wende, Jean ;
Gass, Margery ;
Kotchen, Jane Morley ;
Johnson, Karen C. ;
O'Sullivan, Mary Jo ;
Ockene, Judith K. ;
Chen, Chu ;
Hubbell, F. Allan .
LANCET, 2009, 374 (9697) :1243-1251
[14]   Dissecting the role of mTOR: Lessons from mTOR inhibitors [J].
Dowling, Ryan J. O. ;
Topisirovic, Ivan ;
Fonseca, Bruno D. ;
Sonenberg, Nahum .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03) :433-439
[15]   Starving Neurons Show Sex Difference in Autophagy [J].
Du, Lina ;
Hickey, Robert W. ;
Bayir, Huelya ;
Watkins, Simon C. ;
Tyurin, Vladimir A. ;
Guo, Fengli ;
Kochanek, Patrick M. ;
Jenkins, Larry W. ;
Ren, Jin ;
Gibson, Greg ;
Chu, Charleen T. ;
Kagan, Valerian E. ;
Clark, Robert S. B. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (04) :2383-2396
[16]   Human papillomaviruses and centrosome duplication errors:: modeling the origins of genomic instability [J].
Duensing, S ;
Münger, K .
ONCOGENE, 2002, 21 (40) :6241-6248
[17]   Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer [J].
Egloff, AM ;
Weissfeld, J ;
Land, SR ;
Finn, OJ .
HUMAN IMMUNOLOGY: PATIENT-BASED RESEARCH, 2005, 1062 :29-40
[18]   Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins [J].
Felsani, A. ;
Mileo, A. M. ;
Paggi, M. G. .
ONCOGENE, 2006, 25 (38) :5277-5285
[19]   Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study [J].
Freedman, Neal D. ;
Leitzmann, Michael F. ;
Hollenbeck, Albert R. ;
Schatzkin, Arthur ;
Abnet, Christian C. .
LANCET ONCOLOGY, 2008, 9 (07) :649-656
[20]   Lung cancer, smoke exposure, and sex [J].
Gazdar, Adi F. ;
Thun, Michael J. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :469-471